We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Government decision to defy calls for phased restart unnerves families, and teachers, despite stress of home schooling
Health secretary Matt Hancock praises NHS test and trace for ‘dogged determination’ in tracking individual down
Decision makes approval possible in as little as two weeks after final data is received from manufacturers
Netcompany chief says health status apps are only a short-term solution as pandemic eases
US study likely to alleviate some concerns about new strains outsmarting vaccines
Studies ‘urgently needed’ to check efficacy of current vaccines against strain, researchers say
News about P.1 variant balanced by data confirming vaccines highly effective at preventing disease
Public urged to stick to lockdown rules as regional disparities remain despite falls in UK-wide impact
Sharp drop in infections brings hope, but masks signs of resurgence in parts of Europe
Research provides scientific support for government’s road map out of lockdown
Attitudes are slow to change but equality drive is gaining momentum
Quarantine hotel booking system down for second day as concerns mount about testing regime
Advisers to government warn of national discussion after most vulnerable are vaccinated
Early data need confirmation but government push to extend gap between jabs receives a boost
Agreement with IDT Biologika will boost capacity and help Europe’s supply shortages
Health secretary Matt Hancock announces tough new measures as concerns about Covid variants grow
E484K, the genetic change in the variant first identified in South Africa, is affecting the efficacy of some vaccines
Public health officials have targeted specific locations to contain South African mutation
Push to develop domestic diagnostics industry and less reliance on foreign producers
Vaccine maker under pressure over clinical trial data and manufacturing problems
Scientists say research supports UK plan to delay second dose of Covid-19 vaccine
Research finds prevalence of past infection was nine times higher than national average
Hancock promises to ‘come down hard’ on variant after 11 UK cases found with no connection to country of origin
Studies suggest antibody therapies are less effective against new variants
Imperial College London data show rate of infection close to stable or falling slightly
International Edition